ABCD1 gene — Drug Target
All drugs that target ABCD1 gene — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (1)
- EB-101 · Abeona Therapeutics, Inc · Gene therapy · Neurology
EB-101 is a gene therapy that delivers a functional copy of the ABCD1 gene to restore adrenoleukodystrophy protein function in patients with cerebral adrenoleukodystrophy.